EZETROL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug EZETROL contains one active pharmaceutical ingredient (API):

1 Ezetimibe UNII EOR26LQQ24 - EZETIMIBE

Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol. Read about Ezetimibe

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EZETROL Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AX09	Ezetimibe	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11408K, 8757X
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525500901111216, 525500902116319
Country: CA	Health Products and Food Branch	Identifier(s): 02247521
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 03209545, 03210086, 05371333, 06198871, 07338937, 07338995, 07339003, 07349823, 08768982, 09434792, 09740767, 10188097, 10339449, 10388092, 10751150, 10978936, 11515960, 11515977, 11515983, 12379950, 12379967, 12379973, 12500334, 13197659, 14256401, 15293290, 15415959, 15415994, 15658219, 16622927, 16812148
Country: EE	Ravimiamet	Identifier(s): 1162921, 1162932, 1162943, 1162954, 1162965, 1162987, 1162998, 1163001, 1163012, 1205468, 1241389
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65376, BE249094, BE249094IP, PA-1286-061, PA-1286-061-001, PA1286-061, PL00025-0609, PL00025-0609IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 013386, 013485
Country: FR	Base de données publique des médicaments	Identifier(s): 60981789, 62056326, 67841576, 69355352
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 196124, 44957
Country: HK	Department of Health Drug Office	Identifier(s): 51223
Country: IE	Health Products Regulatory Authority	Identifier(s): 17025, 23263, 23275
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4668
Country: IT	Agenzia del Farmaco	Identifier(s): 036016145
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004296, 1004297, 1017601, 1017602, 1025402, 1025403, 1053764, 1053765, 1053766, 1053767, 1053768, 1053769, 1053770, 1053771, 1053772, 1053773, 1053774, 1053775, 1053776, 1053777, 1053778, 1053779, 1053780, 1053781, 1053782, 1053783
Country: MT	Medicines Authority	Identifier(s): AA1438/00901, AA770/13201, AA908/21901
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 579M2002
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 70645
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100137078
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68118001, W68118005, W68118006
Country: SG	Health Sciences Authority	Identifier(s): 12375P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337169
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/7.5/0413